Latest Breaking News On - Clarus therapeutics - Page 12 : comparemela.com

Settlement With Clarus Therapeutics On July 14, 2021, Lipocine Inc entered into a global settlement and license agreement with Clarus Therapeutics Inc (Clarus) to resolve all outstanding claims in the ongoing intellectual property battle between the two companies as well as the ongoing interference proceeding between the two companies. Both companies agreed to dismiss the Lipocine Inc. v Clarus Therapeutics, Inc., No 19-cv-622 (WCB) litigation presently pending in the U.S. District Court for the District of Delaware and interference proceedings captioned Clarus Therapeutics, Inc. v. Lipocine Inc., Interference No. 106,128 presently pending in the U.S. Patent and Trademark. The terms of the settlement remain confidential.

United statesRaymond james human health innovation conferenceClarus therapeutics incDrug administrationLipocine incUs district courtInternational liver congressClarus therapeuticsLadenburg thalmann healthcare conferenceEuropean associationDigital eventLytham partners summerInvestigational new drug applicationPatent infringement caseClarus therapeuticJudge bryson